September 05, 2013
Genentech Inc. and a unit of parent company Roche Holding Ltd. sued Mylan Pharmaceuticals Inc. and an Actavis Inc. unit Wednesday in Delaware federal court, accusing their rivals of infringing a patent covering anti-viral Valcyte with their planned generic versions of the drug.